Glucose dehydrogenase
View Patent ↗Modified water-soluble glucose dehydrogenases having pyrrolo-quinoline quinone as a coenzyme are provided wherein at least one amino acid residue is replaced by another amino acid residue in a specific region. Modified water-soluble PQQGDHs of the present invention have improved affinity for glucose.
1. An isolated mutant glucose dehydrogenase consisting of the amino acid sequence of SEQ ID NO:1 and having pyrrolo-quinoline quinone as a coenzyme, wherein said mutant consists of one mutation, a substitution of asparagine at position 438 with aspartate, and wherein said mutant has glucose dehydrogenase activity.
2. An isolated modified mutant glucose dehydrogenase consisting of the amino acid sequence of SEQ ID NO:1 and having pyrrolo-quinoline quinone as a coenzyme, wherein said mutant consists of one mutation, a substitution of asparagine at position 428 with threonine, lysine, isoleucine, histidine or aspartate, and wherein said mutant has glucose dehydrogenase activity.
3. An isolated mutant glucose dehydrogenase consisting of the amino acid sequence of SEQ ID NO:1 and having pyrrolo-quinoline quinone as a coenzyme, wherein said mutant consists of one mutation, a substitution of lysine at position 431 with isoleucine, and wherein said mutant has glucose dehydrogenase activity.
4. An isolated mutant glucose dehydrogenase consisting of the amino acid sequence of SEQ ID NO:1 and having pyrrolo-quinoline quinone as a coenzyme, wherein said mutant consists of one mutation, a substitution of aspartate at position 432 with asparagine, and wherein said mutant has glucose dehydrogenase activity.
5. An isolated mutant glucose dehydrogenase consisting of the amino acid sequence of SEQ ID NO:1 and having pyrrolo-quinoline quinone as a coenzyme, wherein said mutant consists of one mutation, a substitution of aspartate at position 433 with asparagine, and wherein said mutant has glucose dehydrogenase activity.
6. An isolated mutant glucose dehydrogenase consisting of the amino acid sequence of SEQ ID NO:1 and having pyrrolo-quinoline quinone as a coenzyme, wherein said mutant consists of one mutation, a substitution of aspartate at position 424 with asparagine, and wherein said mutant has glucose dehydrogenase activity.
7. An isolated mutant glucose dehydrogenase consisting of the amino acid sequence of SEQ ID NO:1 and having pyrrolo-quinoline quinone as a coenzyme, wherein said mutant consists of one mutation, a substitution of glutamate at position 253 with alanine, asparagine, lysine, aspartate, histidine, glutamine, valine or glycine, and wherein said mutant has glucose dehydrogenase activity.
8. An isolated mutant water-soluble glucose dehydrogenase consisting of the amino acid sequence of SEQ ID NO:1 and having pyrrolo-quinoline quinone as a coenzyme, wherein said mutant consists of one mutation, a substitution of isoleucine at position 254 with phenylalanine, and wherein said mutant has glucose dehydrogenase activity.
9. An isolated mutant water-soluble glucose dehydrogenase consisting of the amino acid sequence of SEQ ID NO:1 and having pyrrolo-quinoline quinone as a coenzyme, wherein said mutant consists of one mutation, a substitution of asparagine at position 255 with histidine, and wherein said mutant has glucose dehydrogenase activity.
10. An isolated mutant glucose dehydrogenase consisting of the amino acid sequence of SEQ ID NO:1 and having pyrrolo-quinoline quinone as a coenzyme, wherein said mutant consists of at least one mutation selected from the group consisting of:
(1) asparagine at position 438 substituted with aspartate,
(2) asparagine at position 428 substituted with threonine, lysine, isoleucine, histidine or aspartate;
(3) lysine at position 431 substituted with isoleucine,
(4) aspartate at position 432 substituted with asparagine;
(5) aspartate at position 433 substituted with asparagine;
(6) aspartate at position 424 substituted with asparagine;
(7) glutamate at position 253 substituted with alanine, asparagine, lysine, aspartate, histidine, glutamine, valine or glycine;
(8) isoleucine at position 254 substituted with phenylalanine; and
(9) asparagine at position 255 substituted with histidine, and wherein said mutant has glucose dehydrogenase activity.